Comment on: Intravenous ferric carboxymaltose for iron deficiency anemia or iron deficiency without anemia after poor response to oral iron treatment: Benefits and risks in a cohort of 144 children and adolescents.

Schmugge, M.; Mattiello, V.; Hengartner, H.; von der Weid, N.; Renella, R.

doi:10.1002/pbc.28726

Comment on: Intravenous ferric carboxymaltose for iron deficiency anemia or iron deficiency without anemia after poor response to oral iron treatment: Benefits and risks in a cohort of 144 children and adolescents.

Details

Request a copy

Serval ID

serval:BIB_E4C27BBC82AD

Type

Article: article from journal or magazin.

Publication sub-type

Letter (letter): Communication to the publisher.

Collection

Publications

Institution

UNIL/CHUV

Title

Comment on: Intravenous ferric carboxymaltose for iron deficiency anemia or iron deficiency without anemia after poor response to oral iron treatment: Benefits and risks in a cohort of 144 children and adolescents.

Journal

Pediatric blood & cancer

Author(s)

Schmugge M., Mattiello V., Hengartner H., von der Weid N., Renella R.

Working group(s)

SPOG Pediatric Hematology Working Group

ISSN

1545-5017 (Electronic)

ISSN-L

1545-5009

Publication state

Published

Issued date

03/2021

Peer-reviewed

Oui

Volume

68

Number

3

Pages

e28726

Language

english

Notes

Publication types: Letter
Publication Status: ppublish

Keywords

Pediatrics, Perinatology, and Child Health, Oncology, Hematology

OAI-PMH

oai:serval.unil.ch:BIB_E4C27BBC82AD

DOI

10.1002/pbc.28726

Pubmed

32969156

Web of science

000572077600001

Create date

30/09/2020 9:32

Last modification date

13/03/2021 6:22

Usage data

SERVAL

serveur académique lausannois

Comment on: Intravenous ferric carboxymaltose for iron deficiency anemia or iron deficiency without anemia after poor response to oral iron treatment: Benefits and risks in a cohort of 144 children and adolescents.

Details